![Shanghai Lily & Beauty Cosmetics Co Ltd Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/sse/605136.png?tr=w-200)
Shanghai Lily & Beauty Cosmetics Co Ltd
SSE:605136
![Shanghai Lily & Beauty Cosmetics Co Ltd Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/sse/605136.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/sse/605136.png)
Shanghai Lily & Beauty Cosmetics Co Ltd
Total Current Liabilities
Shanghai Lily & Beauty Cosmetics Co Ltd
Total Current Liabilities Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/baba.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/pdd.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/hkex/6618.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/hkex/3690.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/hkex/9618.png)
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Shanghai Lily & Beauty Cosmetics Co Ltd
SSE:605136
|
Total Current Liabilities
ÂĄ500.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Total Current Liabilities
ÂĄ421.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
27%
|
![]() |
Pinduoduo Inc
NASDAQ:PDD
|
Total Current Liabilities
ÂĄ151.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
![]() |
JD Health International Inc
HKEX:6618
|
Total Current Liabilities
ÂĄ16.4B
|
CAGR 3-Years
52%
|
CAGR 5-Years
107%
|
CAGR 10-Years
N/A
|
![]() |
Meituan
HKEX:3690
|
Total Current Liabilities
ÂĄ87.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
![]() |
JD.Com Inc
HKEX:9618
|
Total Current Liabilities
ÂĄ246.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
31%
|
See Also
What is Shanghai Lily & Beauty Cosmetics Co Ltd's Total Current Liabilities?
Total Current Liabilities
500.4m
CNY
Based on the financial report for Dec 31, 2023, Shanghai Lily & Beauty Cosmetics Co Ltd's Total Current Liabilities amounts to 500.4m CNY.
What is Shanghai Lily & Beauty Cosmetics Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-9%
Over the last year, the Total Current Liabilities growth was -24%. The average annual Total Current Liabilities growth rates for Shanghai Lily & Beauty Cosmetics Co Ltd have been -14% over the past three years , -9% over the past five years .